flow trial semaglutide all-cause mortality hazard ratio Lower risk of cardiovascular events in patients initiated on 2.4 mg in the real‐world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in Cardiovascular risk reduction with once-weekly

What to do: Take progress photos and measurements

Missed dose: Missed dose should be administered as soon as possible within 4 days

The formula is injected just beneath the surface of the skin to increase hydration, improve elasticity, and smooth out fine lines and wrinkles

Decision Guide Prefer a big app + multiple drug paths and dont mind prepay

Tirzepatide Both medications are highly effective, with some key differences: Semaglutide GLP-1 agonist, 15-17% average weight loss Tirzepatide Dual GIP/GLP-1, up to 22% average weight loss Administration Both are weekly subcutaneous injections Your Choice We help determine which is right for you Results Timeline Weight loss results develop progressively as your body adjusts to treatment: Week 1-4 Reduced appetite and initial weight loss begins Month 2-3 5-10% body weight loss typically achieved Month 4-6 Significant weight loss, improved energy Month 6-12 Maximum results, 15-25% weight loss Is It Right For You